470 filings
8-K
OPRX
OptimizeRx Corp
29 Apr 24
1Q24 revenue expected to grow over 40% year-over-year and come in between
4:30pm
ARS
2023 FY
OPRX
OptimizeRx Corp
29 Apr 24
Annual report to shareholders
8:38am
DEF 14A
OPRX
OptimizeRx Corp
Definitive proxy
29 Apr 24
8:35am
8-K
OPRX
OptimizeRx Corp
18 Apr 24
OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results
4:30pm
10-K
2023 FY
OPRX
OptimizeRx Corp
Annual report
15 Apr 24
4:41pm
8-K
hte9vw682vcsiqf
2 Apr 24
Entry into a Material Definitive Agreement
4:05pm
NT 10-K
szc giekwee
28 Mar 24
Notice of late annual filing
8:15am
8-K
65f2yfa7spdb z6
11 Mar 24
OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023
5:04pm
8-K
zk6bbg23c7
26 Jan 24
OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape
4:00pm
8-K/A
orwckrdtjhudr gqurlx
5 Jan 24
Financial Statements and Exhibits
5:19pm
8-K
cbgz qyizdso44lh
6 Nov 23
OptimizeRx Reports Third Quarter 2023 Financial Results
7:15am
8-K
0ivp08 ub8n
25 Oct 23
Entry into a Material Definitive Agreement
4:00pm
8-K
bloxyos 81xhvc
16 Oct 23
OptimizeRx Announces Agreement to Acquire Medicx Health for $95 million to Expand its Omnichannel Reach to Consumers
4:31pm
8-K
fuoqdbu
14 Aug 23
OptimizeRx Reports Second Quarter 2023 Financial Results
4:05pm
8-K
9la3 p7g7
7 Jun 23
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
2iy nsmw40dh
10 May 23
OptimizeRx Reports First Quarter 2023 Financial Results
4:15pm